4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-037981
President and CEO sold 18,333 shares at an average $61.40 ($1,125,648)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2021-06-01 | Sale | −13,127 | $60.98 | $800,511 | 2,215,948 | I |
| Watts Ryan J. President and CEO | 2021-06-01 | Sale | −2,750 | $62.09 | $170,748 | 2,213,198 | I |
| Watts Ryan J. President and CEO | 2021-06-01 | Sale | −2,102 | $62.76 | $131,911 | 2,211,096 | I |
| Watts Ryan J. President and CEO | 2021-06-01 | Sale | −354 | $63.50 | $22,479 | 2,210,742 | I |
| Open-market sales · 18,333 sh · avg $61.40 · $1,125,648 | |||||||
Loading xslF345X03/doc4.xml…